Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106588612A details ionic liquid catalysis for 5-chloro-1-indanone. Achieve high purity and cost reduction in agrochemical intermediate manufacturing with scalable solutions.
Advanced synthesis of pazopanib hydrochloride intermediates via safe reductive amination. Cost-effective, scalable routes for API manufacturing supply chains.
Novel patent CN107176948A offers safer Pimobendan synthesis. Eliminating toxic reagents ensures supply chain reliability and cost reduction for pharmaceutical manufacturers.
Novel Cu/Fe catalytic method for indanone compounds. High yield, scalable process for pharmaceutical intermediates. Cost-effective supply chain solution.
Patent CN105732377B reveals high-yield indanone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112961086B details a novel Rh-catalyzed one-step synthesis of 2-methylene-1-indanone derivatives, offering significant cost reduction in API manufacturing and scalable production.
Novel 3-step route for Procaterol Impurity I from patent CN112645875A. High yield, scalable process for API quality control and reference standards.
Novel room-temperature asymmetric catalysis for chiral secondary aryl alcohols. Reduces cost by eliminating noble metals. High yield and ee for pharma intermediates.
Patent CN116041207A reveals a novel chiral spiroindane ligand enabling high-selectivity C-H activation. Discover cost-effective synthesis and supply chain advantages.
Patent CN108689815B details a novel copper-catalyzed method for indanone synthesis, offering significant cost reduction and green chemistry advantages for pharmaceutical manufacturing.
Novel one-step iridium-catalyzed method for fluorine-containing secondary amines using stable fluorinated alcohols, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN105408302B reveals advanced purification method. Enhances supply chain reliability and drives cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Novel aldol condensation method for Donepezil key intermediate using toluene solvent, offering high purity and yield for industrial scale-up.
Novel two-step route for Orforglipron intermediate. High purity, scalable process reduces cost and supply chain risks for pharmaceutical manufacturing.
Advanced synthesis of 5-[(2R)-2-aminopropyl]-1-[3-(benzoyloxy)propyl]-7-cyano-1H-indole salt via oxidative dehydrogenation for superior pharmaceutical quality control and supply reliability.
Novel boron-catalyzed hydroamination method offers high yield and mild conditions for pharmaceutical intermediates manufacturing ensuring supply chain reliability.
Novel synthetic route for 5-chloro-1-indanone using 3-chlorobenzaldehyde. Reduces environmental pollution and simplifies scale-up for agrochemical intermediate manufacturing.
Efficient synthesis of fused polycyclic compounds via Rh-catalysis. Cost-effective pharmaceutical intermediate manufacturing with high purity and scalability for global supply chains.
Novel patent CN106674011B reveals DMSO-based route for indanone derivatives offering reduced toxicity and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN116396189A details a novel B(C6F5)3 catalyzed route for high-purity (S)-(+)-1-indanyl isocyanate, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.